Medicure Announces FDA Approval Received for Prexxartan®

December 19, 2017

Responsive image

WINNIPEG, Dec. 19, 2017 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today announced that Carmel Biosciences, Inc. (“Carmel”) has received final approval of its New Drug Application from the US Food and Drug Administration…

Category: Precious Metals